Clearbridge BioMedics diagnoses SG$9m

Mar 17, 2013 • Global Corporate Venturing

Medical tech company spun off from National University of Singapore hits B round.

Clearbridge BioMedics, medical tech company spun off from National University of Singapore, has raised SG$9m ($7.2m) in its series B round.

Vertex Venture, a venture capital subsidiary of Singapore state-owned investment company Temasek, led the B round, which also included VC firm BioVeda Capital, the government’s co-funding scheme, Spring Seeds Capital, Clearbridge Biomedical Sciences Accelerator, a wholly-owned SG$40m investment subsidiary of Clearbridge Accelerator (CBA), and Lu Yoh Chie, Biosensors International founder and existing shareholder.

Clearbridge BioMedics uses its CTChips system to detect, isolate, and retrieve tumour cells from blood samples.

Clearbridge BioMedics uses its CTChips system to detect, isolate, and retrieve tumour cells from blood samples.

Clearbridge BioMedics, a medical tech company spun off from National University of Singapore, has raised SG$9m ($7.2m) in its series B round.

Vertex Venture, a venture capital [VC] subsidiary of Singapore state-owned investment company Temasek, led the B round, which also included VC firm BioVeda Capital, the government’s co-funding scheme, Spring Seeds Capital, Clearbridge Biomedical Sciences Accelerator, a wholly-owned SG$40m investment subsidiary of Clearbridge Accelerator (CBA), and Lu Yoh Chie, Biosensors International founder and existing shareholder.

Clearbridge BioMedics uses its CTChips system to detect, isolate, and retrieve tumour cells from blood samples.

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

The CVC Funding Round Database

Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.

CVC Directory

Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.

Corporate venture building report

Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes

Events

All events

About us

GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.